Torrance, CA, United States of America

Thilini Fernando

This inventor holds 2 USPTO granted patents. Top assignees: University of California, Zinfanite Technologies, Inc.. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thilini Fernando. Retrieved from https://idiyas.com/inventor/thilini-fernando

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2018-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Thilini Fernando: Innovator in Cancer Research

Introduction

Thilini Fernando is a notable inventor based in Torrance, California. He has made significant contributions to the field of cancer research, particularly in understanding the role of long intergenic non-coding RNAs (lincRNAs) in leukemia.

Latest Patents

Thilini Fernando holds 1 patent related to his research. His patent, titled "Methods and compositions involving lincRNA and leukemia," focuses on the association of lincRNA expression with specific cytogenetic abnormalities. This research is crucial for understanding the disease pathogenesis of certain cancers, especially B acute lymphoblastic leukemia (B-ALL). The patent provides methods and compositions regarding B-ALL associated long intergenic RNAs (BALIRs), highlighting the importance of lincRNAs in gene regulation.

Career Highlights

Thilini Fernando is affiliated with the University of California, where he conducts his research. His work has contributed to advancing the understanding of cancer biology and potential therapeutic approaches.

Collaborations

Thilini has collaborated with notable colleagues, including Dinesh S Rao and Ella Waters, to further his research endeavors.

Conclusion

Thilini Fernando's innovative work in cancer research exemplifies the critical role of inventors in advancing medical science. His contributions to understanding lincRNAs in leukemia are paving the way for future breakthroughs in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…